Drugs that contain Tiotropium Bromide

1. List of Spiriva drug patents

SPIRIVA's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7070800 BOEHRINGER INGELHEIM Inhalable powder containing tiotropium
Jan, 2022

(1 year, 2 months ago)

US7309707

(Pediatric)

BOEHRINGER INGELHEIM Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
Mar, 2022

(1 year, 9 days ago)

US6908928

(Pediatric)

BOEHRINGER INGELHEIM Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
Mar, 2022

(1 year, 9 days ago)

US7642268

(Pediatric)

BOEHRINGER INGELHEIM Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
Mar, 2022

(1 year, 9 days ago)

US6777423

(Pediatric)

BOEHRINGER INGELHEIM Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
Mar, 2022

(1 year, 9 days ago)

USRE38912

(Pediatric)

BOEHRINGER INGELHEIM Process for preparing powder formulations
Apr, 2022

(11 months ago)

US7070800

(Pediatric)

BOEHRINGER INGELHEIM Inhalable powder containing tiotropium
Jul, 2022

(8 months ago)

US8022082 BOEHRINGER INGELHEIM Method for the administration of an anticholinergic by inhalation
Jan, 2026

(2 years from now)

US8022082

(Pediatric)

BOEHRINGER INGELHEIM Method for the administration of an anticholinergic by inhalation
Jul, 2026

(3 years from now)

US7694676 BOEHRINGER INGELHEIM Dry powder inhaler
Mar, 2027

(3 years from now)

US7694676

(Pediatric)

BOEHRINGER INGELHEIM Dry powder inhaler
Sep, 2027

(4 years from now)

US9010323 BOEHRINGER INGELHEIM Inhaler and sieve for an inhaler
Apr, 2030

(7 years from now)

Market Authorisation Date: 30 January, 2004

Treatment: For the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema; Administration of an inha...

Dosage: POWDER;INHALATION

How can I launch a generic of SPIRIVA before it's patent expiration?
More Information on Dosage

SPIRIVA family patents

17

United States

11

European Union

6

Japan

5

Australia

5

Germany

5

Spain

5

Poland

5

Canada

4

Denmark

4

Hong Kong

4

Portugal

4

China

EA

4

EA

4

New Zealand

4

ME

3

Israel

3

South Africa

3

Mexico

3

Slovenia

3

Hungary

3

Uruguay

3

Norway

3

Argentina

3

Croatia

3

Brazil

YU

3

Yugoslavia

3

Malaysia

3

Korea, Republic of

3

Peru

3

Taiwan, Province of China

3

Ukraine

2

Austria

2

Slovakia

2

Egypt

2

Saudi Arabia

2

Czech Republic

2

Ecuador

2

Bulgaria

2

Estonia

OA

1

OA

1

Turkey

1

Morocco

1

Costa Rica

1

Cuba

AP

1

AP

1

Algeria

1

Cyprus

1

Iceland

1

Georgia

2. List of Spiriva Respimat drug patents

SPIRIVA RESPIMAT's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7988001

(Pediatric)

BOEHRINGER INGELHEIM Container provided with a pressure equalization opening
Feb, 2022

(1 year, 1 month ago)

US7284474 BOEHRINGER INGELHEIM Piston-pumping system having o-ring seal properties
Aug, 2024

(1 year, 4 months from now)

US7284474

(Pediatric)

BOEHRINGER INGELHEIM Piston-pumping system having o-ring seal properties
Feb, 2025

(1 year, 10 months from now)

US7896264 BOEHRINGER INGELHEIM Microstructured high pressure nozzle with built-in filter function
May, 2025

(2 years from now)

US7896264

(Pediatric)

BOEHRINGER INGELHEIM Microstructured high pressure nozzle with built-in filter function
Nov, 2025

(2 years from now)

US7396341 BOEHRINGER INGELHEIM Blocking device for a locking stressing mechanism having a spring-actuated output drive device
Oct, 2026

(3 years from now)

US9027967 BOEHRINGER INGELHEIM Device for clamping a fluidic component
Mar, 2027

(3 years from now)

US7396341

(Pediatric)

BOEHRINGER INGELHEIM Blocking device for a locking stressing mechanism having a spring-actuated output drive device
Apr, 2027

(4 years from now)

US9027967

(Pediatric)

BOEHRINGER INGELHEIM Device for clamping a fluidic component
Oct, 2027

(4 years from now)

US7837235 BOEHRINGER INGELHEIM Device for clamping a fluidic component
Mar, 2028

(4 years from now)

US7837235

(Pediatric)

BOEHRINGER INGELHEIM Device for clamping a fluidic component
Sep, 2028

(5 years from now)

US8733341 BOEHRINGER INGELHEIM Atomizer and method of atomizing fluid with a nozzle rinsing mechanism
Oct, 2030

(7 years from now)

US8733341

(Pediatric)

BOEHRINGER INGELHEIM Atomizer and method of atomizing fluid with a nozzle rinsing mechanism
Apr, 2031

(8 years from now)

Market Authorisation Date: 24 September, 2014

Treatment: NA

Dosage: SPRAY, METERED;INHALATION

More Information on Dosage

SPIRIVA RESPIMAT family patents

12

European Union

9

Germany

9

United States

6

Japan

5

Spain

5

Canada

4

Denmark

4

Austria

4

Australia

3

South Africa

3

Mexico

3

Slovenia

3

Colombia

3

Brazil

3

Portugal

3

Cyprus

3

Korea, Republic of

3

Poland

3

China

2

Hong Kong

2

Uruguay

2

Norway

2

Argentina

2

Croatia

2

Peru

2

Taiwan, Province of China

2

Ecuador

2

Ukraine

EA

2

EA

2

New Zealand

1

Israel

1

Egypt

1

Russia

YU

1

Yugoslavia

1

Malaysia

1

RS

1

ME

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic